There were 2,099 press releases posted in the last 24 hours and 445,344 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image